Back
BCB Bancorp Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
9
BCBP
BCB Bancorp
Last Price:
$9.69
Seasonality Move:
-3.45%
Buy
55
SRPT
Sarepta Therapeutics
Last Price:
$98.39
Seasonality Move:
6.73%
Sell
9
BCB Bancorp (BCBP)
is a Sell
Is BCB Bancorp a Buy, Sell or Hold?
-
The current BCB Bancorp [BCBP] share price is $9.78. The Score for BCBP is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
-
BCBP is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
55
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCBP Stock Price Chart
What is BCB Bancorp's stock price today?
-
The BCB Bancorp share price today is $9.78Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCBP is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $99.77Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
BCBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.35 | Sell |
Relative Strength Index (14 RSI): | 37.27 | Sell |
Chaikin Money Flow: | 6783 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.87 - 10.61) | Sell |
Bollinger Bands (100): | (10.66 - 12.9) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.4 | Sell |
Relative Strength Index (14 RSI): | 37.2 | Sell |
Chaikin Money Flow: | -420668 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (103.16 - 112.22) | Sell |
Bollinger Bands (100): | (109.63 - 127.19) | Sell |
BCBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.86 | Sell |
20-day SMA: | 10.1 | Sell |
50-day SMA: | 10.87 | Sell |
200-day SMA: | 11.56 | Sell |
8-day EMA: | 9.85 | Sell |
20-day EMA: | 10.14 | Sell |
50-day EMA: | 10.78 | Sell |
200-day EMA: | 11.5 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.49 | Sell |
20-day SMA: | 106.07 | Sell |
50-day SMA: | 113.88 | Sell |
200-day SMA: | 126.52 | Sell |
8-day EMA: | 103.1 | Sell |
20-day EMA: | 106.21 | Sell |
50-day EMA: | 111.8 | Sell |
200-day EMA: | 120.79 | Sell |
BCB Bancorp Earnings Growth & BCBP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.06 per share, and an increase next year of $0.44 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.
BCB Bancorp Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |